Skip to main content
OpenTrials

Clinical trial condition

Colorectal Cancer

Explore clinical trials studying Colorectal Cancer. Study availability and eligibility vary by location and protocol.

2,458 public trials 451 recruiting studies
Refine in advanced search Browse all conditions

Colorectal Cancer trial results

Completed

A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China

NCT04121286

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +55 more
Locations
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical Collage Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
View Trial Details
Completed

A Study of LY2880070 in Participants With Advanced or Metastatic Cancer

NCT02632448

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +55 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
View all 16 locations
View Trial Details
Completed

A Study of BLYG8824A in Participants With Locally Advanced or Metastatic Colorectal Cancer

NCT04468607

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • City of Hope Duarte, California, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
  • Clinica Universitaria de Navarra Pamplona, Navarre, Spain
View Trial Details
Completed

A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment

NCT03428958

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +13 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Vanderbilt University Nashville, Tennessee, United States
View Trial Details
Completed

A Study to Assess Efficacy of RXC004 +/- Nivolumab in Ring Finger Protein 43 (RNF43) or R-spondin (RSPO) Aberrated, Metastatic, Microsatellite Stable, Colorectal Cancer After Progression on Standard of Care (SOC)

NCT04907539

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Providence Medical Foundation Santa Rosa, California, United States
  • Community Health Network Cancer Center North - Community Hospital Network Indianapolis, Indiana, United States
  • OptumCare Cancer Care Las Vegas, Nevada, United States
  • UT MD Anderson Cancer Center Houston, Texas, United States
View all 22 locations
View Trial Details

Related conditions